Difference between revisions of "Part:BBa K3117040"

 
(→‎MIT MAHE 2020)
 
(4 intermediate revisions by 3 users not shown)
Line 2: Line 2:
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K3117040 short</partinfo>
 
<partinfo>BBa_K3117040 short</partinfo>
−
 
−
...
 
−
 
−
<!-- Add more about the biology of this part here
 
 
===Usage and Biology===
 
===Usage and Biology===
 +
Part BBa_K3117039 is the constant region 1 (CH1) within an antibody. Together with the single chain variable fragment and the Igk light chain (<partinfo>BBa_K3117039</partinfo>) the constant region 1 forms the antigen-binding fragment (Fab) of an antibody.
  
 
<!-- -->
 
<!-- -->
−
<span class='h3bb'>Sequence and Features</span>
 
−
<partinfo>BBa_K3117040 SequenceAndFeatures</partinfo>
 
  
 +
==MIT_MAHE 2020==
 +
'''Summary'''
  
−
<!-- Uncomment this to enable Functional Parameter display
+
The constant region 1 (CH1) within an antibody. Together with the single chain variable fragment and the Igk light chain, the constant region 1 forms the antigen-binding fragment (Fab) of an antibody. Ig are heterodimeric proteins composed of two H and two L chains. Each L chain contains either a Ck or a Cl and a VL domain that helps define the Ag-binding site of the Ab. In addition to a variable domain, each H chain contains between three and four constant domains that specify the effector function of the Ab.
−
===Functional Parameters===
+
 
−
<partinfo>BBa_K3117040 parameters</partinfo>
+
==References==
−
<!-- -->
+
 
 +
1. Kaplon, H., & Reichert, J. M. (2019). Antibodies to watch in 2019. mAbs, 11(2), 219–238. https://doi.org/10.1080/19420862.2018.1556465
 +
 
 +
2. Kaplon, H., & Reichert, J. M. (2018). Antibodies to watch in 2018. mAbs, 10(2), 183–203. https://doi.org/10.1080/19420862.2018.1415671
 +
 
 +
3. Gilliland, G. L., Luo, J., Vafa, O., & Almagro, J. C. (2012). Leveraging SBDD in protein therapeutic development: antibody engineering. Methods in molecular biology (Clifton, N.J.), 841, 321–349. https://doi.org/10.1007/978-1-61779-520-6_14
 +
 
 +
4. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic acids research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
 +
 
 +
5. Pritsch, O., Hudry-Clergeon, G., Buckle, M., Petillot, Y., Bouvet, J. P., Gagnon, J., & Dighiero, G. (1996). Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies?. The Journal of clinical investigation, 98(10), 2235–2243. https://doi.org/10.1172/JCI119033 "

Latest revision as of 18:16, 23 October 2020


constant region 1 (CH1) of an antibody

Usage and Biology

Part BBa_K3117039 is the constant region 1 (CH1) within an antibody. Together with the single chain variable fragment and the Igk light chain (BBa_K3117039) the constant region 1 forms the antigen-binding fragment (Fab) of an antibody.


MIT_MAHE 2020

Summary

The constant region 1 (CH1) within an antibody. Together with the single chain variable fragment and the Igk light chain, the constant region 1 forms the antigen-binding fragment (Fab) of an antibody. Ig are heterodimeric proteins composed of two H and two L chains. Each L chain contains either a Ck or a Cl and a VL domain that helps define the Ag-binding site of the Ab. In addition to a variable domain, each H chain contains between three and four constant domains that specify the effector function of the Ab.

References

1. Kaplon, H., & Reichert, J. M. (2019). Antibodies to watch in 2019. mAbs, 11(2), 219–238. https://doi.org/10.1080/19420862.2018.1556465

2. Kaplon, H., & Reichert, J. M. (2018). Antibodies to watch in 2018. mAbs, 10(2), 183–203. https://doi.org/10.1080/19420862.2018.1415671

3. Gilliland, G. L., Luo, J., Vafa, O., & Almagro, J. C. (2012). Leveraging SBDD in protein therapeutic development: antibody engineering. Methods in molecular biology (Clifton, N.J.), 841, 321–349. https://doi.org/10.1007/978-1-61779-520-6_14

4. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic acids research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235

5. Pritsch, O., Hudry-Clergeon, G., Buckle, M., Petillot, Y., Bouvet, J. P., Gagnon, J., & Dighiero, G. (1996). Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies?. The Journal of clinical investigation, 98(10), 2235–2243. https://doi.org/10.1172/JCI119033 "